US Patent Issued to Institut Curie, Honing Biosciences, Centre National de la Recherche Scientifique, The University of Zurich on April 7 for "Single domain antibodies and their use in cancer therapies" (French, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,302, issued on April 7, was assigned to Institut Curie (Paris), Honing Biosciences (Paris), Centre National de la Recherche Scientifique (Paris) and The University of Zurich (Zurich).

"Single domain antibodies and their use in cancer therapies" was invented by Sandrine Moutel (Paris), Franck Perez (Paris), Michele Bernasconi (Zollikon, Switzerland), Nagjie Laila Alijaj (Zurich) and Zelia Gouveia (Orly, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to fully humanized anti-FGFR4 single domain antibodies (sdAbs) and variants thereof. The present invention further relates to functionalized drug nanocarriers, nucle...